154 related articles for article (PubMed ID: 21282486)
1. Blood storage duration and biochemical recurrence of cancer after radical prostatectomy.
Cata JP; Klein EA; Hoeltge GA; Dalton JE; Mascha E; O'Hara J; Russell A; Kurz A; Ben-Elihayhu S; Sessler DI
Mayo Clin Proc; 2011 Feb; 86(2):120-7. PubMed ID: 21282486
[TBL] [Abstract][Full Text] [Related]
2. Effect of perioperative blood transfusion on prostate cancer recurrence.
Ford BS; Sharma S; Rezaishiraz H; Huben RS; Mohler JL
Urol Oncol; 2008; 26(4):364-7. PubMed ID: 18367097
[TBL] [Abstract][Full Text] [Related]
3. Blood transfusion had no influence on the 5-year biochemical recurrence after robot-assisted radical prostatectomy: a retrospective study.
Han J; Jeon YT; Ryu JH; Oh AY; Kim H; Bae YK; Koo CH
BMC Urol; 2021 Nov; 21(1):160. PubMed ID: 34789219
[TBL] [Abstract][Full Text] [Related]
4. Perioperative Blood Transfusion as a Significant Predictor of Biochemical Recurrence and Survival after Radical Prostatectomy in Patients with Prostate Cancer.
Kim JK; Kim HS; Park J; Jeong CW; Ku JH; Kim HH; Kwak C
PLoS One; 2016; 11(5):e0154918. PubMed ID: 27159369
[TBL] [Abstract][Full Text] [Related]
5. Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer.
Han M; Partin AW; Zahurak M; Piantadosi S; Epstein JI; Walsh PC
J Urol; 2003 Feb; 169(2):517-23. PubMed ID: 12544300
[TBL] [Abstract][Full Text] [Related]
6. Is anastomotic biopsy necessary before radiotherapy after radical prostatectomy?
Koppie TM; Grossfeld GD; Nudell DM; Weinberg VK; Carroll PR
J Urol; 2001 Jul; 166(1):111-5. PubMed ID: 11435834
[TBL] [Abstract][Full Text] [Related]
7. Length of positive surgical margin after radical prostatectomy as a predictor of biochemical recurrence.
Shikanov S; Song J; Royce C; Al-Ahmadie H; Zorn K; Steinberg G; Zagaja G; Shalhav A; Eggener S
J Urol; 2009 Jul; 182(1):139-44. PubMed ID: 19450829
[TBL] [Abstract][Full Text] [Related]
8. Predictors of biochemical recurrence after Retzius-sparing robot-assisted radical prostatectomy: Analysis of 359 cases with a median follow-up period of 26 months.
Abdel Raheem A; Chang KD; Alenzi MJ; Ham WS; Han WK; Choi YD; Rha KH
Int J Urol; 2018 Dec; 25(12):1006-1014. PubMed ID: 30276864
[TBL] [Abstract][Full Text] [Related]
9. PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer.
Roberts SG; Blute ML; Bergstralh EJ; Slezak JM; Zincke H
Mayo Clin Proc; 2001 Jun; 76(6):576-81. PubMed ID: 11393495
[TBL] [Abstract][Full Text] [Related]
10. [Stored autologous blood transfusion does not increase recurrence of prostate cancer after radical prostatectomy: A preliminary study].
Zhang Y; Zhang XS; Zhao SP; Li X; Liu SX; Li WH
Zhonghua Nan Ke Xue; 2019 May; 25(5):430-433. PubMed ID: 32216229
[TBL] [Abstract][Full Text] [Related]
11. Predictive factors of biochemical recurrence after radical prostatectomy for high-risk prostate cancer.
Murata Y; Tatsugami K; Yoshikawa M; Hamaguchi M; Yamada S; Hayakawa Y; Ueda K; Momosaki S; Sakamoto N
Int J Urol; 2018 Mar; 25(3):284-289. PubMed ID: 29315854
[TBL] [Abstract][Full Text] [Related]
12. Multicenter clinical validation of PITX2 methylation as a prostate specific antigen recurrence predictor in patients with post-radical prostatectomy prostate cancer.
Bañez LL; Sun L; van Leenders GJ; Wheeler TM; Bangma CH; Freedland SJ; Ittmann MM; Lark AL; Madden JF; Hartman A; Weiss G; Castaños-Vélez E
J Urol; 2010 Jul; 184(1):149-56. PubMed ID: 20478579
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Factors for Biochemical Recurrence More than 10 Years after Radical Prostatectomy.
Liesenfeld L; Kron M; Gschwend JE; Herkommer K
J Urol; 2017 Jan; 197(1):143-148. PubMed ID: 27418452
[TBL] [Abstract][Full Text] [Related]
14. Time to prostate specific antigen recurrence after radical prostatectomy and risk of prostate cancer specific mortality.
Freedland SJ; Humphreys EB; Mangold LA; Eisenberger M; Partin AW
J Urol; 2006 Oct; 176(4 Pt 1):1404-8. PubMed ID: 16952644
[TBL] [Abstract][Full Text] [Related]
15. Effect of autologous blood transfusion on the rate of biochemical recurrence after radical prostatectomy.
Gallina A; Briganti A; Chun FK; Walz J; Hutterer GC; Erbersdobler A; Eichelberg C; Schlomm T; Ahyai SA; Perrotte P; Saad F; Montorsi F; Huland H; Graefen M; Karakiewicz PI
BJU Int; 2007 Dec; 100(6):1249-53. PubMed ID: 17850374
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer recurrence in radical surgery patients receiving autologous or homologous blood.
Ness PM; Walsh PC; Zahurak M; Baldwin ML; Piantadosi S
Transfusion; 1992 Jan; 32(1):31-6. PubMed ID: 1370592
[TBL] [Abstract][Full Text] [Related]
17. [Perioperative parameters and prognosis analysis of patients aged 80 years or older treated with radical prostatectomy for prostate cancer].
Zhang F; Zhang SD; Xiao CL; Huang Y; Ma LL
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Oct; 50(5):822-827. PubMed ID: 30337742
[TBL] [Abstract][Full Text] [Related]
18. Postoperative early ultrasensitive prostate-specific antigen identifies patients at risk for biochemical recurrence in margin positive prostate cancers: a single-center study.
Hatano K; Okusa T; Ishizuya Y; Nakai Y; Nakayama M; Kakimoto KI; Nishimura K
Jpn J Clin Oncol; 2017 Jan; 47(1):74-79. PubMed ID: 27733509
[TBL] [Abstract][Full Text] [Related]
19. Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy.
Kupelian PA; Katcher J; Levin HS; Klein EA
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1043-52. PubMed ID: 9169811
[TBL] [Abstract][Full Text] [Related]
20. Reassessment of the risk factors for biochemical recurrence in D'Amico intermediate-risk prostate cancer treated using radical prostatectomy.
Narita S; Mitsuzuka K; Tsuchiya N; Koie T; Kawamura S; Ohyama C; Tochigi T; Yamaguchi T; Arai Y; Habuchi T;
Int J Urol; 2015 Nov; 22(11):1029-35. PubMed ID: 26290306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
